Non-coding rnas in kidney diseases: The long and short of them

58Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Recent progress in genomic research has highlighted the genome to be much more transcribed than expected. The formerly so-called junk DNA encodes a miscellaneous group of largely unknown RNA transcripts, which contain the long non-coding RNAs (lncRNAs) family. lncRNAs are instrumental in gene regulation. Moreover, understanding their biological roles in the physiopathology of many diseases, including renal, is a new challenge. lncRNAs regulate the effects of microRNAs (miRNA) on mRNA expression. Understanding the complex crosstalk between lncRNA– miRNA–mRNA is one of the main challenges of modern molecular biology. This review aims to summarize the role of lncRNA on kidney diseases, the molecular mechanisms involved, and their function as emerging prognostic biomarkers for both acute and chronic kidney diseases. Finally, we will also outline new therapeutic opportunities to diminish renal injury by targeting lncRNA with antisense oligonucleotides.

Cite

CITATION STYLE

APA

Moreno, J. A., Hamza, E., Guerrero-Hue, M., Rayego-Mateos, S., García-Caballero, C., Vallejo-Mudarra, M., … Metzinger-Le Meuth, V. (2021, June 1). Non-coding rnas in kidney diseases: The long and short of them. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms22116077

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free